I read your recent column where you said that ivermectin has not been proven to be an effective treatment for cancer. I feel ...

An Aussie teen has racked up 69 million views on a video revealing what happens to your body when climbing Mt Everest.

An 82-year-old woman with a history of congestive heart failure was admitted to this hospital for volume overload. Ascites, ...

Explore the booming Pulmonary Edema Market, valued at USD 6.6 Bn in 2024 and set to reach USD 12.04 Bn by 2032. Discover key ...

Jascayd’s approval adds to Boehringer’s already prominent position in treating IPF. In 2014, the company won an FDA clearance for Ofev, which has become a pillar of care for IPF and one of ...

Abstract: Numerous people die from lung cancer every year, making it a serious public health issue. Oftentimes, the symptoms of lung cancer manifest only at a later stage, when it is difficult to ...

The last time I spoke about aTyr Pharma, Inc. (NASDAQ:ATYR), it was with respect to a Seeking Alpha article entitled as "aTyr Pharma: Two 2025 Data Readouts Could Provide Inflection Point." As an ...

Edema and fluid overload remain the leading causes of hospitalization and readmission for patients with CHF, cirrhosis, and chronic kidney disease. An estimated 6.7 million Americans live with heart ...

Corstasis Therapeutics Announces FDA Approval of ENBUMYST™ (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease ENBUMYST™ is ...

Department of Ophthalmology, National Taiwan University Hospital, Hsinchu Branch, Hsinchu 302, Taiwan Department of Ophthalmology, National Taiwan University Hospital, Taipei 100, Taiwan Graduate ...